Eli Lilly says on track to meet or exceed mid-term financial goals


Goals include: At least $20B in revenue, at least $3B in net income, at least $4B in operating cash flow. Says poised to return to growth post-2014. Sees potential for up to five NME submissions this year. Comments from slides that will be presented on the Q1 earnings conference call.

View Comments (0)